BioXcel Therapeutics Inc. (BTAI)
NASDAQ: BTAI
· Real-Time Price · USD
5.47
0.72 (15.16%)
At close: Aug 15, 2025, 3:59 PM
6.07
10.98%
After-hours: Aug 15, 2025, 07:58 PM EDT
BioXcel Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -50.95M | -40.06M | -59.6M | -71M | -107.83M | -153.05M | -179.05M | -211.6M | -202.93M | -187.08M | -165.76M | -137.07M | -122.08M | -112.03M | -106.93M | -101.89M | -99.83M | -93.63M |
Depreciation & Amortization | 305K | 307K | 309K | 310K | 312K | 316K | 318K | 321K | 327K | 330K | 327K | 322K | 314K | 309K | 297K | 266K | 237K | 206K |
Stock-Based Compensation | 3.4M | 2.9M | 6.16M | 9.95M | 12.1M | 17.17M | 18.61M | 19.56M | 20.03M | 18.39M | 17.34M | 15.03M | 15.43M | 17.71M | 19.45M | 23.83M | 24.21M | 19.4M |
Other Working Capital | -2.08M | -2.63M | -2.95M | 415K | 3.2M | 6.3M | 10.76M | 10.01M | 13.88M | 7.77M | -371K | -216K | -5.89M | -4.06M | 130K | -2.88M | -1.94M | 528K |
Other Non-Cash Items | -4.47M | -17.63M | -12.86M | 3.71M | 7.8M | 19.15M | 18.81M | 3.71M | 3.48M | 3.04M | 7.42M | 2.33M | 1.82M | 8.43M | 8.79M | 13.69M | 13.81M | 10.78M |
Deferred Income Tax | n/a | n/a | n/a | -15.38M | -15.38M | -15.93M | -15.93M | -545K | -546K | n/a | n/a | 3.88M | 3.88M | 3.88M | 3.88M | -1.02M | -1.02M | -1.02M |
Change in Working Capital | -4.06M | -11.88M | -6.03M | -11.67M | -2.33M | 11.98M | 2.23M | 21.77M | 19.25M | 10.04M | 10.67M | 4.21M | 322K | -969K | 4.98M | -4.74M | -6.01M | 195K |
Operating Cash Flow | -55.77M | -66.36M | -72.03M | -84.08M | -105.33M | -120.36M | -155.01M | -166.78M | -160.38M | -155.28M | -135.34M | -116.63M | -105.65M | -94.93M | -82.15M | -82.49M | -81.39M | -73.83M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | -20K | -20K | -20K | -20K | -19K | -139K | -151K | -168K | -249K | -445K | -703K | -681K | -616K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | n/a | n/a | n/a | n/a | n/a | -20K | -20K | -20K | -20K | -19K | -139K | -151K | -168K | -249K | -445K | -703K | -681K | -616K |
Debt Repayment | -2.5M | -2.5M | -2.5M | n/a | n/a | n/a | n/a | n/a | 30M | 30M | 30M | 30M | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 39.28M | 39.28M | 39.16M | -377K | -377K | -119K | -510K | -208K | -160K | 65.73M | 66.24M | 66.19M | 66.24M | 602K | 1.45M | 1.72M | 1.64M | 1.41M |
Financial Cash Flow | 18.07M | 23.24M | 36.66M | 34.51M | 34.05M | 29M | 26.52M | 24.45M | 54.5M | 120.39M | 96.24M | 96.19M | 66.21M | 101.59M | 102.45M | 102.68M | 289.64M | 188.38M |
Net Cash Flow | -37.7M | -43.13M | -35.37M | -49.57M | -71.27M | -91.38M | -128.5M | -142.35M | -105.91M | -34.91M | -39.24M | -20.6M | -39.6M | 6.42M | 19.85M | 19.48M | 207.56M | 113.94M |
Free Cash Flow | -55.77M | -66.36M | -72.03M | -84.08M | -105.33M | -120.38M | -155.03M | -166.8M | -160.4M | -155.3M | -135.48M | -116.78M | -105.81M | -95.17M | -82.6M | -83.2M | -82.08M | -74.45M |